Company Filing History:
Years Active: 2020
Title: Innovations of Xiaoqing Xu in Non-Systemic TGR5 Agonists
Introduction
Xiaoqing Xu is an accomplished inventor based in Monmouth Junction, NJ (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of non-systemic TGR5 agonists. Her work focuses on innovative compounds that have the potential to treat diabetic diseases in humans.
Latest Patents
Xiaoqing Xu holds 1 patent for her invention titled "Non-systemic TGR5 agonists." This patent describes tricyclic compounds of formula (I) and formula (II), or a pharmaceutically acceptable salt thereof. The compounds are designed to be useful non-systemic TGR5 agonists that can effectively treat diabetic diseases. The invention also provides a pharmaceutical composition containing these tricyclic compounds and outlines methods for their production and use in treating patients with metabolic disorders. Additionally, the compounds may be used in combination with other anti-diabetic drugs.
Career Highlights
Xiaoqing Xu is currently associated with Venenum Biodesign, LLC, where she continues to advance her research and development efforts. Her innovative approach to drug design has positioned her as a key figure in the pharmaceutical industry.
Collaborations
Xiaoqing has collaborated with notable colleagues, including Chia-Yu Huang and Brian F McGuinness. These partnerships have further enhanced her research capabilities and contributed to the success of her projects.
Conclusion
Xiaoqing Xu's work in developing non-systemic TGR5 agonists represents a significant advancement in the treatment of diabetic diseases. Her innovative compounds and dedication to pharmaceutical research continue to make a positive impact in the field.